Court Rules FDA Must Grant Orphan Drug Exclusivity for Bendeka

In a second successful legal challenge of the FDA’s approach to orphan drug designations, a federal court ordered the agency to grant Eagle Pharmaceuticals orphan drug exclusivity for its cancer drug Bendeka.
Source: Drug Industry Daily